NEW
Stock Screener with Intrinsic Value
Royalty Pharma plc (RPRX)
Last Price$30.8(0.6%)
Market Cap$13.8B
70.5%
Industry median - 65.3%
5Y Historical average - 70.4%
75.7%
Industry median - (867.7%)
5Y Historical average - 67.3%
79.5%
Industry median - (726.1%)
5Y Historical average - 94.3%
363.9%
Industry median - 83.4%
5Y Historical average - 192.1%
RPRX Profitability Rating
Crunching data... Almost there!
RPRX Profitability Metrics
Crunching data... Almost there!
Competing with RPRX Profitability
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Royalty Pharma plc (RPRX) gross profit margin?
The Royalty Pharma plc (RPRX) gross profit margin is 70.5%, compared to the industry median of 65.3% and the 5-year historical average of 70.4%.
What is the Royalty Pharma plc (RPRX) operating income margin?
The Royalty Pharma plc (RPRX) operating income margin is 75.7%, compared to the industry median of (867.7%)) and the 5-year historical average of 67.3%.
What is the Royalty Pharma plc (RPRX) Free Cash Flow (FCF) margin?
The Royalty Pharma plc (RPRX) Free Cash Flow margin is 79.5%, compared to the industry median of (726.1%) and the 5-year historical average of 94.3%.
What is the Royalty Pharma plc (RPRX) earnings quality?
The Royalty Pharma plc (RPRX) earnings quality is 363.9%, compared to the industry median of 83.4% and the 5-year historical average of 192.1%.